Neuroendocrine neoplasms (NENs), which are characterized by neuroendocrine
differentiation, can arise in various organs. NENs have been divided into well-differentiated …

Gastrinomas are neuroendocrine neoplasms (NENs), that occur primarily in the duodenum
and pancreas, which ectopically secrete gastrin, resulting in the Zollinger-Ellison syndrome …

This ENETS guidance paper for well‐differentiated nonfunctioning pancreatic
neuroendocrine tumours (NF‐Pan‐NET) has been developed by a multidisciplinary working …

High-grade neuroendocrine neoplasms are a rare disease entity and account for
approximately 10% of all neuroendocrine neoplasms. Because of their rarity, there is an …

Background The optimal treatment for metastatic high-grade gastroenteropancreatic (GEP)
neuroendocrine neoplasms when Ki-67≤ 55% is unknown. A prospective multi-centre …

Insulinomas are hormone-producing pancreatic neuroendocrine neoplasms with an
estimated incidence of 1 to 4 cases per million per year. Extrapancreatic insulinomas are …

Background There are currently no standard first-line treatment options for patients with
higher grade 2–3, well-differentiated, advanced, gastroenteropancreatic neuroendocrine …

Background: Gastroenteropancreatic (GEP) neuroendocrine neoplasms with Ki-67> 20%
were subdivided in the most recent 2019 World Health Organization histopathological …

Neuroendocrine neoplasms (NENs) are a heterogeneous family of tumors of challenging
diagnosis and clinical management. Their incidence and prevalence continue to rise mainly …

Simple Summary Pancreatic neuroendocrine tumors are a rare and heterogenous group of
neoplasms. Surgical resection is the only curative option. However, there has been an …